表紙:プロテオミクスの世界市場予測:2022年~2030年
市場調査レポート
商品コード
1071608

プロテオミクスの世界市場予測:2022年~2030年

Global Proteomics Market Forecast 2022-2030

出版日: | 発行: Inkwood Research | ページ情報: 英文 225 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
プロテオミクスの世界市場予測:2022年~2030年
出版日: 2022年04月26日
発行: Inkwood Research
ページ情報: 英文 225 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプロテオミクスの市場規模は、予測期間である2022年~2030年の間に14.24%のCAGRで拡大すると予測されています。技術の進歩とプロテオミクス研究の進展、そしてその広範な応用が市場成長の原動力となっています。

当レポートでは、世界のプロテオミクス市場について調査し、市場の概要とともに、コンポーネント別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査範囲と調査手法

第2章 エグゼクティブサマリー

第3章 市場力学

  • 主な促進要因
    • プロテオミクス研究の進歩とその広範な応用
    • 技術の進歩
  • 主な抑制要因
    • 非常に高価なサービスと装置
    • 政府およびその他の組織による統一性の低い尽力と取り組み

第4章 主要な分析

  • COVID-19がプロテオミクス市場に与える影響
  • 動向
  • ポーターのファイブフォース分析
  • 機会マトリクス
  • ベンダー情勢
  • 主な購入基準

第5章 コンポーネント別市場

  • 試薬
    • イムノアッセイ
    • 分光法
    • マイクロアレイ
    • X線結晶学
    • 電気泳動
    • クロマトグラフィ
    • タンパク質分画試薬
  • 装置
    • タンパク質マイクロアレイ
    • 分光法
    • クロマトグラフィー
    • 表面プラズモン共鳴
    • 電気泳動
    • タンパク質分画試薬
    • X線結晶学
  • サービス

第6章 用途別市場

  • 創薬
  • 病気の診断
  • その他

第7章 地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 競合情勢

  • 主な戦略的開発
    • 合併と買収
    • 製品の発売と開発
    • パートナーシップと契約
    • 事業拡大
  • 企業プロファイル
    • AGILENT TECHNOLOGIES INC
    • BIOGNOSYS AG
    • BIO-RAD LABORATORIES
    • BRUKER CORPORATION
    • CREATIVE PROTEOMICS
    • DANAHER CORPORATION
    • FIOS GENOMICS
    • JAPAN ELECTRON OPTICS LABORATORY CO LTD(JOEL)
    • MS BIOWORKS
    • PERKINELMER INC
    • PROMEGA CORPORATION
    • SENGENICS
    • SHIMADZU
    • THERMO FISHER SCIENTIFIC INC
    • WATERS CORPORATION
図表

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - PROTEOMICS MARKET
  • TABLE 2: GLOBAL PROTEOMICS MARKET, BY COMPONENTS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 3: GLOBAL PROTEOMICS MARKET, BY COMPONENTS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 4: GLOBAL REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 5: GLOBAL REAGENTS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 6: GLOBAL PROTEOMICS MARKET, BY REAGENTS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 7: GLOBAL PROTEOMICS MARKET, BY REAGENTS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 8: GLOBAL IMMUNOASSAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 9: GLOBAL IMMUNOASSAY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 10: GLOBAL SPECTROSCOPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 11: GLOBAL SPECTROSCOPY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 12: GLOBAL MICROARRAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 13: GLOBAL MICROARRAY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 14: GLOBAL X-RAY CRYSTALLOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 15: GLOBAL X-RAY CRYSTALLOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 16: GLOBAL ELECTROPHORESIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 17: GLOBAL ELECTROPHORESIS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 18: GLOBAL CHROMATOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 19: GLOBAL CHROMATOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 20: GLOBAL PROTEIN FRACTIONATION REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 21: GLOBAL PROTEIN FRACTIONATION REAGENTS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 22: GLOBAL INSTRUMENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 23: GLOBAL INSTRUMENTS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 24: GLOBAL PROTEOMICS MARKET, BY INSTRUMENTS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 25: GLOBAL PROTEOMICS MARKET, BY INSTRUMENTS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 26: GLOBAL PROTEIN MICROARRAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 27: GLOBAL PROTEIN MICROARRAY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 28: GLOBAL SPECTROSCOPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 29: GLOBAL SPECTROSCOPY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 30: GLOBAL PROTEOMICS MARKET, BY SPECTROSCOPY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 31: GLOBAL PROTEOMICS MARKET, BY SPECTROSCOPY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 32: GLOBAL MASS SPECTROMETRY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 33: GLOBAL MASS SPECTROMETRY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 34: GLOBAL NMR SPECTROMETRY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 35: GLOBAL NMR SPECTROMETRY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 36: GLOBAL CHROMATOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 37: GLOBAL CHROMATOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 38: GLOBAL PROTEOMICS MARKET, BY CHROMATOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 39: GLOBAL PROTEOMICS MARKET, BY CHROMATOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 40: GLOBAL HPLC SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 41: GLOBAL HPLC SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 42: GLOBAL AFFINITY CHROMATOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 43: GLOBAL AFFINITY CHROMATOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 44: GLOBAL SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 45: GLOBAL SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 46: GLOBAL ION CHROMATOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 47: GLOBAL ION CHROMATOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 48: GLOBAL SURFACE PLASMON RESONANCE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 49: GLOBAL SURFACE PLASMON RESONANCE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 50: GLOBAL ELECTROPHORESIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 51: GLOBAL ELECTROPHORESIS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 52: GLOBAL PROTEIN FRACTIONATION REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 53: GLOBAL PROTEIN FRACTIONATION REAGENTS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 54: GLOBAL X-RAY CRYSTALLOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 55: GLOBAL X-RAY CRYSTALLOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 56: GLOBAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 57: GLOBAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 58: GLOBAL PROTEOMICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 59: GLOBAL PROTEOMICS MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 60: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 61: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 62: GLOBAL DISEASE DIAGNOSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 63: GLOBAL DISEASE DIAGNOSIS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 64: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 65: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 66: GLOBAL PROTEOMICS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 67: GLOBAL PROTEOMICS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 68: NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 69: NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 70: KEY PLAYERS IN NORTH AMERICA PROTEOMICS MARKET
  • TABLE 71: EUROPE PROTEOMICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 72: EUROPE PROTEOMICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 73: KEY PLAYERS IN EUROPE PROTEOMICS MARKET
  • TABLE 74: ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 75: ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 76: KEY PLAYERS IN ASIA-PACIFIC PROTEOMICS MARKET
  • TABLE 77: REST OF WORLD PROTEOMICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 78: REST OF WORLD PROTEOMICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 79: KEY PLAYERS IN REST OF WORLD PROTEOMICS MARKET
  • TABLE 80: LIST OF MERGERS & ACQUISITIONS
  • TABLE 81: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 82: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 83: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY BUYING CRITERIA
  • FIGURE 6: GLOBAL PROTEOMICS MARKET, GROWTH POTENTIAL, BY COMPONENTS, IN 2021
  • FIGURE 7: GLOBAL PROTEOMICS MARKET, BY REAGENTS, 2022-2030 (IN $ MILLION)
  • FIGURE 8: GLOBAL PROTEOMICS MARKET, GROWTH POTENTIAL, BY REAGENTS, IN 2021
  • FIGURE 9: GLOBAL PROTEOMICS MARKET, BY IMMUNOASSAY, 2022-2030 (IN $ MILLION)
  • FIGURE 10: GLOBAL PROTEOMICS MARKET, BY SPECTROSCOPY, 2022-2030 (IN $ MILLION)
  • FIGURE 11: GLOBAL PROTEOMICS MARKET, BY MICROARRAY, 2022-2030 (IN $ MILLION)
  • FIGURE 12: GLOBAL PROTEOMICS MARKET, BY X-RAY CRYSTALLOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 13: GLOBAL PROTEOMICS MARKET, BY ELECTROPHORESIS, 2022-2030 (IN $ MILLION)
  • FIGURE 14: GLOBAL PROTEOMICS MARKET, BY CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 15: GLOBAL PROTEOMICS MARKET, BY PROTEIN FRACTIONATION REAGENTS, 2022-2030 (IN $ MILLION)
  • FIGURE 16: GLOBAL PROTEOMICS MARKET, BY INSTRUMENTS, 2022-2030 (IN $ MILLION)
  • FIGURE 17: GLOBAL PROTEOMICS MARKET, GROWTH POTENTIAL, BY INSTRUMENTS, IN 2021
  • FIGURE 18: GLOBAL PROTEOMICS MARKET, BY PROTEIN MICROARRAY, 2022-2030 (IN $ MILLION)
  • FIGURE 19: GLOBAL PROTEOMICS MARKET, BY SPECTROSCOPY, 2022-2030 (IN $ MILLION)
  • FIGURE 20: GLOBAL PROTEOMICS MARKET, GROWTH POTENTIAL, BY SPECTROSCOPY, IN 2021
  • FIGURE 21: GLOBAL PROTEOMICS MARKET, BY MASS SPECTROMETRY, 2022-2030 (IN $ MILLION)
  • FIGURE 22: GLOBAL PROTEOMICS MARKET, BY NMR SPECTROMETRY, 2022-2030 (IN $ MILLION)
  • FIGURE 23: GLOBAL PROTEOMICS MARKET, BY CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 24: GLOBAL PROTEOMICS MARKET, GROWTH POTENTIAL, BY CHROMATOGRAPHY, IN 2021
  • FIGURE 25: GLOBAL PROTEOMICS MARKET, BY HPLC SYSTEMS, 2022-2030 (IN $ MILLION)
  • FIGURE 26: GLOBAL PROTEOMICS MARKET, BY AFFINITY CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 27: GLOBAL PROTEOMICS MARKET, BY SUPERCRITICAL FLUID CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 28: GLOBAL PROTEOMICS MARKET, BY ION CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 29: GLOBAL PROTEOMICS MARKET, BY SURFACE PLASMON RESONANCE, 2022-2030 (IN $ MILLION)
  • FIGURE 30: GLOBAL PROTEOMICS MARKET, BY ELECTROPHORESIS, 2022-2030 (IN $ MILLION)
  • FIGURE 31: GLOBAL PROTEOMICS MARKET, BY PROTEIN FRACTIONATION REAGENTS, 2022-2030 (IN $ MILLION)
  • FIGURE 32: GLOBAL PROTEOMICS MARKET, BY X-RAY CRYSTALLOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 33: GLOBAL PROTEOMICS MARKET, BY SERVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 34: GLOBAL PROTEOMICS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
  • FIGURE 35: GLOBAL PROTEOMICS MARKET, BY DRUG DISCOVERY, 2022-2030 (IN $ MILLION)
  • FIGURE 36: GLOBAL PROTEOMICS MARKET, BY DISEASE DIAGNOSIS, 2022-2030 (IN $ MILLION)
  • FIGURE 37: GLOBAL PROTEOMICS MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
  • FIGURE 38: NORTH AMERICA PROTEOMICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 39: UNITED STATES PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 40: CANADA PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 41: EUROPE PROTEOMICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 42: UNITED KINGDOM PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 43: GERMANY PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 44: FRANCE PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 45: ITALY PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 46: SPAIN PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 47: BELGIUM PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 48: POLAND PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 49: REST OF EUROPE PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 50: ASIA-PACIFIC PROTEOMICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 51: CHINA PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 52: JAPAN PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 53: INDIA PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 54: SOUTH GLOBAL PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 55: INDONESIA PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 56: THAILAND PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 57: VIETNAM PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 58: AUSTRALIA & NEW ZEALAND PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 59: REST OF ASIA-PACIFIC PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 60: REST OF WORLD PROTEOMICS MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 61: LATIN AMERICA PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 62: MIDDLE EAST & AFRICA PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
目次
Product Code: 24604

KEY FINDINGS

The global proteomics market is estimated to project a CAGR of 14.24% during the forecast period, 2022-2030. The technological advancements and the advancing proteomics study, and its wide-scale applications drive the market growth.

MARKET INSIGHTS

Proteomics is the large-scale study of proteomes and is used to investigate where and when proteins are expressed, how proteins are modified, and the rates of steady-state abundance, protein production, and degradation. Also, it can offer relevant biological information for several biological problems.

Proteomics is a relatively new and dynamic science branch that focuses on evaluating gene expression at the proteome level. With growing research efforts, in terms of technical and monetary, proteomics is projected to incorporate technologies that can be applied to the tissue and serum samples for extracting important biological information in the form of biomarkers to help scientists and clinicians to understand the dynamic biology of their system of interest.

Further, advancements in proteomic research facilitate relevant contributions to the development of personalized medicine by accelerating the detection of protein biochips & pharmacoprotemics, proteomics-based molecular diagnostics, and protein biomarkers. Personalized medicines are an effective approach against cancer, rare genetic conditions, and neurodegenerative diseases.

REGIONAL INSIGHTS

The global proteomics market growth assessment includes the analysis of Asia-Pacific, Europe, North America, and Rest of World. North America is evaluated to fare the highest in terms of revenue share in the global market by 2030. This is attributed to advancing technologies and increased awareness.

COMPETITIVE INSIGHTS

The market competition is fierce, with companies contesting in a relatively small market. Some of the leading firms in the market include Biognosys AG, Shimadzu, Danaher Corporation, Thermo Fisher Scientific Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. ADVANCES IN PROTEOMICS STUDY AND ITS WIDE-SCALE APPLICATIONS
    • 3.1.2. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. HIGHLY EXPENSIVE SERVICES AND INSTRUMENTATION
    • 3.2.2. LOW UNIFIED EFFORTS AND INITIATIVES BY GOVERNMENTS AND OTHER ORGANISATIONS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON PROTEOMICS MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. KEY BUYING CRITERIA

5. MARKET BY COMPONENTS

  • 5.1. REAGENTS
    • 5.1.1. IMMUNOASSAY
    • 5.1.2. SPECTROSCOPY
    • 5.1.3. MICROARRAY
    • 5.1.4. X-RAY CRYSTALLOGRAPHY
    • 5.1.5. ELECTROPHORESIS
    • 5.1.6. CHROMATOGRAPHY
    • 5.1.7. PROTEIN FRACTIONATION REAGENTS
  • 5.2. INSTRUMENTS
    • 5.2.1. PROTEIN MICROARRAY
    • 5.2.2. SPECTROSCOPY
      • 5.2.2.1. MASS SPECTROMETRY
      • 5.2.2.2. NMR SPECTROMETRY
    • 5.2.3. CHROMATOGRAPHY
      • 5.2.3.1. HPLC SYSTEMS
      • 5.2.3.2. AFFINITY CHROMATOGRAPHY
      • 5.2.3.3. SUPERCRITICAL FLUID CHROMATOGRAPHY
      • 5.2.3.4. ION CHROMATOGRAPHY
    • 5.2.4. SURFACE PLASMON RESONANCE
    • 5.2.5. ELECTROPHORESIS
    • 5.2.6. PROTEIN FRACTIONATION REAGENTS
    • 5.2.7. X-RAY CRYSTALLOGRAPHY
  • 5.3. SERVICES

6. MARKET BY APPLICATION

  • 6.1. DRUG DISCOVERY
  • 6.2. DISEASE DIAGNOSIS
  • 6.3. OTHER APPLICATIONS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. MARKET SIZE & ESTIMATES
    • 7.1.2. KEY GROWTH ENABLERS
    • 7.1.3. KEY CHALLENGES
    • 7.1.4. KEY PLAYERS
    • 7.1.5. COUNTRY ANALYSIS
      • 7.1.5.1. UNITED STATES
      • 7.1.5.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. MARKET SIZE & ESTIMATES
    • 7.2.2. KEY GROWTH ENABLERS
    • 7.2.3. KEY CHALLENGES
    • 7.2.4. KEY PLAYERS
    • 7.2.5. COUNTRY ANALYSIS
      • 7.2.5.1. UNITED KINGDOM
      • 7.2.5.2. GERMANY
      • 7.2.5.3. FRANCE
      • 7.2.5.4. ITALY
      • 7.2.5.5. SPAIN
      • 7.2.5.6. BELGIUM
      • 7.2.5.7. POLAND
      • 7.2.5.8. REST OF EUROPE
  • 7.3. ASIA-PACIFIC
    • 7.3.1. MARKET SIZE & ESTIMATES
    • 7.3.2. KEY GROWTH ENABLERS
    • 7.3.3. KEY CHALLENGES
    • 7.3.4. KEY PLAYERS
    • 7.3.5. COUNTRY ANALYSIS
      • 7.3.5.1. CHINA
      • 7.3.5.2. JAPAN
      • 7.3.5.3. INDIA
      • 7.3.5.4. SOUTH KOREA
      • 7.3.5.5. INDONESIA
      • 7.3.5.6. THAILAND
      • 7.3.5.7. VIETNAM
      • 7.3.5.8. AUSTRALIA & NEW ZEALAND
      • 7.3.5.9. REST OF ASIA-PACIFIC
  • 7.4. REST OF WORLD
    • 7.4.1. MARKET SIZE & ESTIMATES
    • 7.4.2. KEY GROWTH ENABLERS
    • 7.4.3. KEY CHALLENGES
    • 7.4.4. KEY PLAYERS
    • 7.4.5. REGIONAL ANALYSIS
      • 7.4.5.1. LATIN AMERICA
      • 7.4.5.2. MIDDLE EAST & AFRICA

8. COMPETITIVE LANDSCAPE

  • 8.1. KEY STRATEGIC DEVELOPMENTS
    • 8.1.1. MERGERS & ACQUISITIONS
    • 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 8.1.3. PARTNERSHIPS & AGREEMENTS
    • 8.1.4. BUSINESS EXPANSIONS
  • 8.2. COMPANY PROFILES
    • 8.2.1. AGILENT TECHNOLOGIES INC
    • 8.2.2. BIOGNOSYS AG
    • 8.2.3. BIO-RAD LABORATORIES
    • 8.2.4. BRUKER CORPORATION
    • 8.2.5. CREATIVE PROTEOMICS
    • 8.2.6. DANAHER CORPORATION
    • 8.2.7. FIOS GENOMICS
    • 8.2.8. JAPAN ELECTRON OPTICS LABORATORY CO LTD (JOEL)
    • 8.2.9. MS BIOWORKS
    • 8.2.10. PERKINELMER INC
    • 8.2.11. PROMEGA CORPORATION
    • 8.2.12. SENGENICS
    • 8.2.13. SHIMADZU
    • 8.2.14. THERMO FISHER SCIENTIFIC INC
    • 8.2.15. WATERS CORPORATION